Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions
CA 2398428 C · Owner: The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services · Inventors: Kapikian, Albert; Chanock, Robert; Vesikari, Timo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compositions for making a medicament and methods for the administration of a vaccine compositions for protection against human rotaviral disease without significant reactogenicity. Human x rhesus reassortant rotavirus compositions were made which when administered during the first 7 to about 10 days of life provided a composition which was , non-reactogenic followed by booster immunizations at 16 to 18 weeks or 14 to 20 weeks, up to 1 year of age. The immune response induced by the initial neonatal administration of the live rotavirus vaccine composition protects the infant from the reactogenicity of the composition when administered as a second …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 26, 2001 and granted September 8, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.